Department of Stomatology, The Third Affiliated Hospital of Soochow University, The First People's Hospital of Changzhou City, Changzhou, China.
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):641-648. doi: 10.26355/eurrev_201901_16878.
The aim of this study was to investigate the role of microRNA-625-3p in the occurrence and progression of oral squamous cell carcinoma (OSCC) and its underlying mechanism.
Expression levels of microRNA-625-3p, SCAI and E-cadherin in OSCC tissues and paracancerous tissues were detected by quantitative real time-polymerase chain reaction (qRT-PCR). MicroRNA-625-3p expression in OSCC tissues with different tumor stages and lymph node metastasis stages was analyzed. Survival analyses were conducted to access the diagnostic values of microRNA-625-3p and SCAI in OSCC. The effect of microRNA-625-3p on regulating cell migration of OSCC was detected by transwell assay. Luciferase reporter gene assay was conducted to verify the binding condition between microRNA-625-3p and SCAI. Rescue experiments were performed by co-transfection of microRNA-625-3p inhibitor and si-SCAI, followed by cell proliferation detection.
MicroRNA-625-3p was highly expressed in OSCC tissues than that of paracancerous tissues. OSCC patients with T3+T4 presented higher expression of microRNA-625-3p than those with T1+T2. Similarly, OSCC patients with N1+N2 presented higher expression of microRNA-625-3p than those with N0. Luciferase reporter gene assay identified that SCAI is the target gene of microRNA-625-3p. Furthermore, we found that SCAI and E-cadherin are lowly expressed in OSCC tissues than that of paracancerous tissues. ROC curve showed that microRNA-625-3p and SCAI exert certain values in diagnosing OSCC. MicroRNA-625-3p promoted migration of OSCC cells, which was reversed by SCAI knockdown.
MicroRNA-625-3p is highly expressed in OSCC, which promotes cell migration of OSCC by regulating SCAI expression.
本研究旨在探讨 microRNA-625-3p 在口腔鳞状细胞癌(OSCC)发生发展中的作用及其潜在机制。
采用实时荧光定量聚合酶链反应(qRT-PCR)检测 OSCC 组织及癌旁组织中 microRNA-625-3p、SCAI 和 E-cadherin 的表达水平。分析不同肿瘤分期和淋巴结转移分期的 OSCC 组织中 microRNA-625-3p 的表达。通过生存分析评估 microRNA-625-3p 和 SCAI 在 OSCC 中的诊断价值。通过 Transwell 实验检测 microRNA-625-3p 对 OSCC 细胞迁移的调控作用。通过荧光素酶报告基因实验验证 microRNA-625-3p 与 SCAI 的结合情况。通过共转染 microRNA-625-3p 抑制剂和 si-SCAI 进行挽救实验,然后进行细胞增殖检测。
microRNA-625-3p 在 OSCC 组织中的表达高于癌旁组织。T3+T4 期 OSCC 患者的 microRNA-625-3p 表达高于 T1+T2 期患者。同样,N1+N2 期 OSCC 患者的 microRNA-625-3p 表达高于 N0 期患者。荧光素酶报告基因实验鉴定 SCAI 是 microRNA-625-3p 的靶基因。此外,我们发现 SCAI 和 E-cadherin 在 OSCC 组织中的表达低于癌旁组织。ROC 曲线表明,microRNA-625-3p 和 SCAI 对 OSCC 的诊断具有一定价值。microRNA-625-3p 促进 OSCC 细胞迁移,而 SCAI 敲低则逆转了这一作用。
microRNA-625-3p 在 OSCC 中高表达,通过调节 SCAI 的表达促进 OSCC 细胞迁移。